GlassScriptPhysician profile
Jose C Ortiz
NPI 1649341843
$2,502.58
in general payments reported to CMS, 2019-2025
26 companies · $25.27 in 2025
The $25.27 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,016 · 2020: $402 · 2022: $58.91 · 2025: $25.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $540.11 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $225.17 | 2019-2020 | |
| Amgen INC. | $208.82 | 2019-2020 | |
| Amarin Pharma, INC. | $183.81 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $165.14 | 2019-2020 | |
| Glaxosmithkline, LLC. | $140.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $123.93 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.55 | 2019 | |
| Novo Nordisk INC | $110.34 | 2019-2022 | |
| Allergan, INC. | $87.85 | 2019-2020 | |
| Pfizer INC. | $74.31 | 2019-2020 | |
| Radius Health, INC. | $68.11 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $65.06 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $60.91 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $49.25 | 2019 | |
| Sunovion Pharmaceuticals INC. | $45.06 | 2019 | |
| Abbvie INC. | $25.27 | 2025 | |
| Mannkind Corporation | $24.35 | 2019 | |
| Hikma Pharmaceuticals USA | $23.78 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $21.57 | 2019 | |
| Avanir Pharmaceuticals, INC. | $21.05 | 2019 | |
| Ge Healthcare | $20.19 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.62 | 2019 | |
| Lilly USA, LLC | $13.22 | 2019 | |
| Avion Pharmaceuticals | $12.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.